Loading...

FITC anti-mouse/human CD44 Antibody FITC anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7
C57BL/6 splenocytes stained with IM7 FITC
  • IM7
    C57BL/6 splenocytes stained with IM7 FITC
  • IM7_FITC_060710
    Human peripheral blood lymphocytes stained with IM7 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103021 25 tests DKK250
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103005 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103006 500 µg DKK654
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103022 100 tests DKK666
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
µg sizes: 0.5 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  2. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  3. Qu L, et al. 2022. Cell. 185:1728. PubMed
  4. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  5. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  6. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  7. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  8. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  9. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  10. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  11. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  12. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  13. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  14. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  15. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  16. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  17. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  18. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  19. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  20. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  21. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  22. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  23. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  24. Israelow B, et al. 2020. bioRxiv. . PubMed
  25. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  26. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  27. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  28. Wang D, et al. 2018. Immunity. 48:659. PubMed
  29. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  30. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  31. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  32. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  33. Dong L, et al. 2021. Cancer Cell. . PubMed
  34. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  35. Diao L, et al. 2022. iScience. 25:105511. PubMed
  36. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  37. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  38. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  39. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  40. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  41. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  42. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  43. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  44. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  45. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  46. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  47. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  48. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  49. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  50. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  51. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  52. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  53. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  54. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  55. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  56. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  57. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  58. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  59. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  60. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  61. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  62. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  63. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  64. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  65. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  66. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  67. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  68. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  69. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  70. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  71. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  72. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  73. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  74. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  75. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  76. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  77. Wan X, et al. 2018. Nature. 560:107. PubMed
  78. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  79. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  80. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  81. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  82. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  83. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  84. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  85. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  86. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  87. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  88. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  89. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  90. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  91. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  92. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  93. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  94. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  95. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  96. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  97. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  98. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  99. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  100. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  101. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  102. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  103. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  104. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  105. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  106. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  107. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  108. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  109. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  110. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  111. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  112. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  113. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  114. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  115. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  116. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  117. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  118. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  119. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  120. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  121. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  122. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  123. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  124. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  125. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  126. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  127. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  128. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  129. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  130. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  131. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  132. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  133. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  134. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  135. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  136. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  137. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  138. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  139. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  140. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  141. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  142. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  143. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  144. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  145. Qu L, et al. 2022. Cell. 185:1728. PubMed
  146. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  147. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  148. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  149. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  150. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  151. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  152. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  153. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  154. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  155. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  156. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  157. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  158. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  159. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  160. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  161. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  162. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  163. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  164. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  165. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  166. Israelow B, et al. 2020. bioRxiv. . PubMed
  167. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  168. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  169. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  170. Wang D, et al. 2018. Immunity. 48:659. PubMed
  171. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  172. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  173. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  174. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  175. Dong L, et al. 2021. Cancer Cell. . PubMed
  176. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  177. Diao L, et al. 2022. iScience. 25:105511. PubMed
  178. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  179. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  180. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  181. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  182. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  183. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  184. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  185. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  186. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  187. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  188. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  189. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  190. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  191. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  192. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  193. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  194. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  195. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  196. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  197. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  198. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  199. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  200. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  201. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  202. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  203. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  204. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  205. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  206. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  207. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  208. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  209. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  210. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  211. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  212. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  213. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  214. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  215. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  216. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  217. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  218. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  219. Wan X, et al. 2018. Nature. 560:107. PubMed
  220. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  221. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  222. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  223. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  224. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  225. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  226. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  227. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  228. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  229. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  230. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  231. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  232. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  233. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  234. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  235. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  236. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  237. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  238. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  239. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  240. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  241. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  242. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  243. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  244. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  245. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  246. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  247. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  248. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  249. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  250. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  251. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  252. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  253. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  254. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  255. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  256. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  257. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  258. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  259. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  260. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  261. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  262. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  263. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  264. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  265. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  266. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  267. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  268. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  269. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  270. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  271. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  272. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  273. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  274. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  275. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  276. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  277. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  278. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  279. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  280. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  281. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  282. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  283. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  284. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021)
AB_312956 (BioLegend Cat. No. 103005)
AB_312957 (BioLegend Cat. No. 103006)
AB_493685 (BioLegend Cat. No. 103022)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 2    Revision Date: 09/11/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7
C57BL/6 splenocytes stained with IM7 FITC
  • IM7
    C57BL/6 splenocytes stained with IM7 FITC
  • IM7_FITC_060710
    Human peripheral blood lymphocytes stained with IM7 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103021 25 tests DKK250
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103005 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103006 500 µg DKK654
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103022 100 tests DKK666
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
µg sizes: 0.5 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  2. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  3. Qu L, et al. 2022. Cell. 185:1728. PubMed
  4. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  5. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  6. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  7. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  8. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  9. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  10. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  11. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  12. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  13. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  14. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  15. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  16. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  17. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  18. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  19. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  20. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  21. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  22. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  23. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  24. Israelow B, et al. 2020. bioRxiv. . PubMed
  25. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  26. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  27. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  28. Wang D, et al. 2018. Immunity. 48:659. PubMed
  29. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  30. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  31. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  32. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  33. Dong L, et al. 2021. Cancer Cell. . PubMed
  34. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  35. Diao L, et al. 2022. iScience. 25:105511. PubMed
  36. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  37. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  38. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  39. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  40. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  41. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  42. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  43. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  44. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  45. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  46. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  47. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  48. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  49. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  50. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  51. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  52. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  53. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  54. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  55. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  56. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  57. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  58. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  59. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  60. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  61. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  62. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  63. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  64. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  65. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  66. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  67. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  68. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  69. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  70. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  71. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  72. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  73. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  74. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  75. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  76. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  77. Wan X, et al. 2018. Nature. 560:107. PubMed
  78. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  79. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  80. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  81. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  82. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  83. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  84. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  85. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  86. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  87. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  88. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  89. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  90. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  91. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  92. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  93. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  94. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  95. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  96. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  97. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  98. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  99. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  100. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  101. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  102. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  103. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  104. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  105. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  106. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  107. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  108. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  109. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  110. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  111. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  112. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  113. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  114. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  115. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  116. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  117. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  118. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  119. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  120. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  121. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  122. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  123. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  124. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  125. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  126. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  127. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  128. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  129. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  130. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  131. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  132. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  133. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  134. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  135. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  136. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  137. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  138. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  139. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  140. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  141. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  142. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  143. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  144. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  145. Qu L, et al. 2022. Cell. 185:1728. PubMed
  146. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  147. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  148. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  149. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  150. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  151. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  152. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  153. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  154. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  155. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  156. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  157. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  158. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  159. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  160. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  161. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  162. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  163. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  164. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  165. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  166. Israelow B, et al. 2020. bioRxiv. . PubMed
  167. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  168. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  169. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  170. Wang D, et al. 2018. Immunity. 48:659. PubMed
  171. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  172. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  173. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  174. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  175. Dong L, et al. 2021. Cancer Cell. . PubMed
  176. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  177. Diao L, et al. 2022. iScience. 25:105511. PubMed
  178. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  179. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  180. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  181. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  182. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  183. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  184. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  185. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  186. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  187. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  188. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  189. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  190. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  191. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  192. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  193. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  194. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  195. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  196. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  197. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  198. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  199. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  200. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  201. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  202. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  203. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  204. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  205. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  206. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  207. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  208. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  209. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  210. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  211. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  212. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  213. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  214. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  215. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  216. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  217. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  218. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  219. Wan X, et al. 2018. Nature. 560:107. PubMed
  220. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  221. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  222. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  223. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  224. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  225. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  226. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  227. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  228. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  229. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  230. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  231. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  232. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  233. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  234. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  235. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  236. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  237. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  238. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  239. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  240. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  241. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  242. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  243. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  244. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  245. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  246. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  247. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  248. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  249. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  250. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  251. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  252. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  253. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  254. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  255. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  256. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  257. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  258. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  259. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  260. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  261. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  262. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  263. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  264. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  265. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  266. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  267. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  268. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  269. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  270. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  271. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  272. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  273. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  274. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  275. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  276. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  277. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  278. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  279. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  280. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  281. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  282. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  283. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  284. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021)
AB_312956 (BioLegend Cat. No. 103005)
AB_312957 (BioLegend Cat. No. 103006)
AB_493685 (BioLegend Cat. No. 103022)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 2    Revision Date: 09/11/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account